Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2025-12-25 @ 7:10 PM
Study NCT ID:
NCT00227032
Status:
TERMINATED
Last Update Posted:
2012-03-06
First Post:
2005-09-23
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Erlotinib in Treating Patients With Progressive Glioblastoma Multiforme
Sponsor:
UNC Lineberger Comprehensive Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-09
Start Date Type:
None
Primary Completion Date:
2008-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2008-03
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-23
First Submit QC Date:
None
Study First Post Date:
2005-09-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-03-05
Last Update Post Date:
2012-03-06
Last Update Post Date Type:
ESTIMATED